242
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population

ORCID Icon, , , , &
Pages 683-690 | Received 28 May 2021, Accepted 13 Sep 2021, Published online: 24 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gema Requena, Alexandrosz Czira, Victoria Banks, Robert Wood, Theo Tritton, Catherine Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix JF Herth, Jennifer K Quint & Afisi S Ismaila. (2023) Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2039-2054.
Read now
Alexandrosz Czira, Gema Requena, Victoria Banks, Robert Wood, Theo Tritton, Catherine M Castillo, Jie Yeap, Rosie Wild, Chris Compton, Kieran J Rothnie, Felix Herth, Jennifer K Quint & Afisi S Ismaila. (2023) Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 643-659.
Read now

Articles from other publishers (2)

Faith S. Luyster, Monique Y. Boudreaux-Kelly & Jessica M. Bon. (2023) Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs. Respiratory Research 24:1.
Crossref
Jiachen Li, Lirong Liang, Siyu Cao, Hengmo Rong, Lin Feng, Di Zhang, Shuilian Chu, Hang Jing & Zhaohui Tong. (2022) Secular trend and risk factors of 30-day COPD-related readmission in Beijing, China. Scientific Reports 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.